Journal article
Deubiquitinase USP13 maintains glioblastoma stem cells by antagonizing FBXL14-mediated Myc ubiquitination
The Journal of experimental medicine, Vol.214(1), pp.245-267
01/01/2017
DOI: 10.1084/jem.20151673
PMCID: PMC5206492
PMID: 27923907
Abstract
Glioblastoma is the most lethal brain tumor and harbors glioma stem cells (GSCs) with potent tumorigenic capacity. The function of GSCs in tumor propagation is maintained by several core transcriptional regulators including c-Myc. c-Myc protein is tightly regulated by posttranslational modification. However, the posttranslational regulatory mechanisms for c-Myc in GSCs have not been defined. In this study, we demonstrate that the deubiquitinase USP13 stabilizes c-Myc by antagonizing FBXL14-mediated ubiquitination to maintain GSC self-renewal and tumorigenic potential. USP13 was preferentially expressed in GSCs, and its depletion potently inhibited GSC proliferation and tumor growth by promoting c-Myc ubiquitination and degradation. In contrast, overexpression of the ubiquitin E3 ligase FBXL14 induced c-Myc degradation, promoted GSC differentiation, and inhibited tumor growth. Ectopic expression of the ubiquitin-insensitive mutant T58A-c-Myc rescued the effects caused by FBXL14 overexpression or USP13 disruption. These data suggest that USP13 and FBXL14 play opposing roles in the regulation of GSCs through reversible ubiquitination of c-Myc.
Details
- Title: Subtitle
- Deubiquitinase USP13 maintains glioblastoma stem cells by antagonizing FBXL14-mediated Myc ubiquitination
- Creators
- Xiaoguang Fang - Cleveland Clinic Lerner College of MedicineWenchao Zhou - Cleveland Clinic Lerner College of MedicineQiulian Wu - Cleveland Clinic Lerner College of MedicineZhi Huang - Cleveland Clinic Lerner College of MedicineYu Shi - Southwest HospitalKailin Yang - Cleveland Clinic Lerner College of MedicineCong Chen - Southwest HospitalQi Xie - Cleveland Clinic Lerner College of MedicineStephen C Mack - Cleveland Clinic Lerner College of MedicineXiuxing Wang - Cleveland Clinic Lerner College of MedicineAngel M Carcaboso - Sant Joan de Déu Research FoundationAndrew E Sloan - Case Western Reserve UniversityGaoliang Ouyang - Xiamen UniversityRoger E McLendon - Duke University HospitalXiu-Wu Bian - Southwest HospitalJeremy N Rich - Cleveland Clinic Lerner College of MedicineShideng Bao - Cleveland Clinic Lerner College of Medicine
- Resource Type
- Journal article
- Publication Details
- The Journal of experimental medicine, Vol.214(1), pp.245-267
- DOI
- 10.1084/jem.20151673
- PMID
- 27923907
- PMCID
- PMC5206492
- NLM abbreviation
- J Exp Med
- ISSN
- 0022-1007
- eISSN
- 1540-9538
- Grant note
- R01 CA184090 / NCI NIH HHS S10 RR031537 / NCRR NIH HHS R01 NS091080 / NINDS NIH HHS R01 NS099175 / NINDS NIH HHS S10 OD018205 / NIH HHS
- Language
- English
- Date published
- 01/01/2017
- Academic Unit
- Radiation Oncology
- Record Identifier
- 9984696564302771
Metrics
7 Record Views